Minden Collamore

8 papers receiving 1.3k citations

Minden Collamore's Hit Papers

Phase II Trial of Sorafenib in Metastatic Thyroid Cancer 2009 · 443 citations
4430+5+11Years since publication100200300400

Peers

Minden Collamore
Comparison fields: 5 of 74
  • Endocrinology, Diabetes and Metabolism 647
  • Endocrine and Autonomic Systems 125
  • Aging 29
  • Oncology 381
  • Molecular Biology 372
Replace Katja Kiseljak‐Vassiliades with:
Katja Kiseljak‐Vassiliades United States
Stephen Leong United States
Mary B. Breslin United States
Janice D. Rone United States
Jamila Gupte United States
Ayse Bilge Ozel United States
Sabrina Semprini United Kingdom
Masayo Nakagawa Japan
Judith Reilly United States
K. Kogishi Japan
Minden Collamore relative to Katja Kiseljak‐Vassiliades United States Katja Kiseljak‐Vassiliades's profile →
Citations per field
00.5×2×4×6.6×
Katja Kiseljak‐Vassiliades · 1×
Citations per year

Countries citing papers authored by Minden Collamore

Since Specialization
Citations

This map shows the geographic impact of Minden Collamore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minden Collamore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minden Collamore more than expected).

Fields of papers citing papers by Minden Collamore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minden Collamore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minden Collamore. The network helps show where Minden Collamore may publish in the future.

Co-authors

The 25 scholars most cited alongside Minden Collamore, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Minden Collamore Line = papers co-authored together Minden Collamore links everyone, so they are left out of the graph.

All Works

8 of 8 papers shown
#Work
1
Phase II Trial of Sorafenib in Metastatic Thyroid Cancer
Hit paper breakdown →
2009443
2 2010313
3 2006208
4 2002135
5 2008135
6 200935
7 200627
8 20055

About Minden Collamore

Minden Collamore is a scholar working on Molecular Biology, Oncology, Endocrinology, Diabetes and Metabolism, Cellular and Molecular Neuroscience and Endocrine and Autonomic Systems, having authored 8 papers that have together received 1.3k indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (3 papers), Histone Deacetylase Inhibitors Research (2 papers), Circadian rhythm and melatonin (1 paper), Light effects on plants (1 paper), S100 Proteins and Annexins (1 paper), Polyomavirus and related diseases (1 paper), Multiple Myeloma Research and Treatments (1 paper) and Cancer Treatment and Pharmacology (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (647 citations), Endocrine and Autonomic Systems (125 citations), Aging (29 citations), Oncology (381 citations) and Molecular Biology (372 citations). Minden Collamore has collaborated with scholars based in United States. Frequent co-authors include Manisha H. Shah, Daria Arbogast, Michael R. Grever, Richard T. Kloos, Matthew D. Ringel, Michael V. Knopp, Jiachao Liang, Paul E. Wakely, Vasyl Vasko and Nathan C. Hall. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism, Clinical Cancer Research, Journal of Biological Chemistry and American Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact